Out-licensing: Diagnostic/Antibody-based diagnostics & Musculoskeletal

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..2 of 2 - per page
Order by

A monoclonal antibody that recognises a sub-population of neutrophils that are believed to be in the ‘late’ stages of apoptosis More

A monoclonal antibody that recognises a glycoprotein of unknown function on the surface of apoptotic neutrophils More

Displaying 1..2 of 2 - per page
Order by

Therapeutic target: Age-related disorders (other); Back pain; Birth defects; Bone cancer; Chronic granulomatous disease; Dupuytren's disease; Dyskinesia; Fibrocystic breast disease; Gout; Growth disorders; Hypomobility; Intermittent claudication; Leprosy; Lupus erythematosis; Muscular; Musculoskeletal disorder (other); Scleroderma; Sjogren's syndrome; Skeletal; Trauma, physical; Wasting disease
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.